Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons

Author(s): Pleasure SJ, Page C, Lee VM


NTera 2/cl.D1 (NT2) cells, a human teratocarcinoma cell line, were manipulated following retinoic acid treatment to yield greater than 95% pure cultures of neuronal cells (NT2-N cells). The commitment of NT2-N cells to a stable neuronal phenotype is irreversible as judged by the lack of mitotic activity or phenotypic reversion over a period of 2 months in culture. Furthermore, NT2-N cells express a variety of neuronal markers including many neuronal cytoskeletal proteins, secretory markers, and surface markers. NT2-N cells resemble primary neuronal cultures from rodents morphologically and in density of process outgrowth and, like primary neurons, go on to elaborate processes that differentiate into axons and dendrites. This culture method yields sufficient highly differentiated postmitotic NT2-N cells for both biochemical and molecular biological studies. Indeed, when undifferentiated NT2 cells were stably transfected with a beta- galactosidase (beta-gal) expression plasmid, beta-gal expression was shown to be present in both undifferentiated NT2 and postmitotic NT2-N cells. Thus, the ability to transfect expression plasmids into undifferentiated NT2 cells will allow the introduction of normal and mutant gene products into cells that can then be induced to become stable, postmitotic human neurons. We conclude that NT2 cells and NT2-N cells represent a unique model system for studies of human neurons, and a novel vehicle for the expression of diverse gene products in terminally differentiated polarized neurons.

Similar Articles

Developmental neurotoxicity of industrial chemicals

Author(s): Grandjean P, Landrigan PJ

Neurobehavioural effects of developmental toxicity

Author(s): Grandjean P, Landrigan PJ

A tiered approach to systemic toxicity testing for agricultural chemical safety assessment

Author(s): Doe JE, Boobis AR, Blacker A, Dellarco V, Doerrer NG, et al.

Human in vitro reporter model of neuronal development and early differentiation processes

Author(s): Couillard-Despres S, Quehl E, Altendorfer K, Bentley K, Brady AM, et al.

A human pluripotent stem cell platform for assessing developmental neural toxicity screening

Author(s): Hou Z, Zhang J, Schwartz MP, Stewart R, Page CD, et al.

Towards in vitro DT/DNT testing: Assaying chemical susceptibility in early differentiating NT2 cells

Author(s): Menzner AK, AbolpourMofrad S, Friedrich O, Gilbert DF

Neuropharmacological properties of neurons derived from human stem cells

Author(s): Coyne L, Shan M, Przyborski SA, Hirakawa R, Halliwell RF

Optimizing neuronal differentiation of human pluripotent NT2 stem cells in monolayer cultures

Author(s): AbolpourMofrad S, Kuenzel K, Friedrich O, Gilbert DF